This site is intended for healthcare professionals only
LoginRegister
Gilead Sciences, Kymera Therapeutics ink pact to develop novel oral molecular glue CDK2 degradersGilead Sciences, Kymera Therapeutics ink pact to develop novel oral molecular glue CDK2 degraders
Shilpa Medicare Dabaspet unit gets VAI classification from USFDASMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical...
India imposes anti-dumping duty on six Chinese productsIndia tightens grip on Chinese imports with anti dumping duty on six products
58 Unauthorised Clinical Trials Spark DCGI Ban on VS Hospital, Doctors, Pharma Giants Under Fire58 Unauthorised Clinical Trials Spark DCGI Ban on VS Hospital, Doctors, Pharma Giants Under Fire
CDSCO Panel Clears AstraZenecas Datopotamab for Breast Cancer, Seeks Phase IV TrialLabel Update for AstraZeneca's Olaparib Cleared by CDSCO Panel
Biocon appoints Ekta Agarwal as Interim Company Secretary, Compliance OfficerBiocon Gets CDSCO Panel Nod to Market Trastuzumab PGS in India
Post WHO alert, Novo Nordisk seeks EMA nod for higher dose of obesity treatment WegovyWeight loss drug: Novo Nordisk Wegovy now available in India
ICMR Seeks Partners for Malaria Vaccine CommercialisationBharat Biotech to cut malaria vaccine RTS.S price to under USD 5 for children in endemic countries
Alembic Pharma Viraj Save resigned as Executive Vice President - Sales and MarketingAlembic Pharma Viraj Save resigned as Executive Vice President - Sales and Marketing
Lupin receives USFDA observations for two Pithampur manufacturing UnitsUSFDA okays Lupin Prucalopride Tablets for chronic idiopathic constipation
Procter & Gamble Hygiene and Health Care Gaurav BhartiaP&G Hygiene and Health Care: Gaurav Bhartia to succeed Mrinalini Srinivasan as CFO
AstraZeneca Imfinzi gets USFDA priority reviewDepression medication: JB Pharma gets USFDA nod for Amitriptyline Hydrochloride Tablets
X